XML 29 R17.htm IDEA: XBRL DOCUMENT
v3.20.2

Fair Value of Financial Instruments and Fair Value Measurements | 9 Months Ended
--- | ---
Sep. 30, 2020
Fair Value Disclosures [Abstract] |
Fair Value of Financial Instruments and Fair Value Measurements |
8. | Fair Value of Financial Instruments and Fair Value Measurements
Fair value is the exchange price that would be received for an asset or paid to transfer a liability (exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. There are three levels of inputs that may be used to measure fair values: Level 1 – Quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity has the ability to access as of the measurement date. Level 2 – Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data. Level 3 – Significant unobservable inputs that reflect a company’s own assumptions about the assumptions that market participants would use in pricing an asset or liability. Fair value estimates of the Company’s financial instruments as of September 30, 2020 and December 31, 2019, including methods and assumptions utilized, are set forth below: Schedule of Fair Value, by Balance Sheet Grouping
(Dollars in thousands) |  | As of September 30, 2020 |
|  | Carrying |  |  |  |  |  |  |  |  |  |  |  |  |
|  | amount |  |  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
Financial assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 15,820 |  |  | $ | 15,820 |  |  | $ | - |  |  | $ | - |  |  | $ | 15,820 |
Investment securities available-for-sale |  |  | 299,530 |  |  |  | 2,047 |  |  |  | 297,483 |  |  |  | - |  |  |  | 299,530 |
Bank stocks, at cost |  |  | 4,459 |  |  |  | n/a |  |  |  | n/a |  |  |  | n/a |  |  |  | n/a |
Loans, net |  |  | 728,150 |  |  |  | - |  |  |  | - |  |  |  | 743,867 |  |  |  | 743,867 |
Loans held for sale, net |  |  | 18,253 |  |  |  | - |  |  |  | 18,253 |  |  |  | - |  |  |  | 18,253 |
Accrued interest receivable |  |  | 5,295 |  |  |  | 10 |  |  |  | 1,613 |  |  |  | 3,672 |  |  |  | 5,295 |
Derivative financial instruments |  |  | 2,366 |  |  |  | - |  |  |  | 2,366 |  |  |  | - |  |  |  | 2,366 |
Financial liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Non-maturity deposits |  | $ | (830,344 | ) |  | $ | (830,344 | ) |  | $ | - |  |  | $ | - |  |  | $ | (830,344 | )
Time deposits |  |  | (127,598 | ) |  |  | - |  |  |  | (127,916 | ) |  |  | - |  |  |  | (127,916 | )
FHLB borrowings |  |  | (20,069 | ) |  |  | - |  |  |  | (20,064 | ) |  |  | - |  |  |  | (7,995 | )
Subordinated debentures |  |  | (21,651 | ) |  |  | - |  |  |  | (15,164 | ) |  |  | - |  |  |  | (15,164 | )
Other borrowings |  |  | (8,400 | ) |  |  | - |  |  |  | (8,400 | ) |  |  | - |  |  |  | (8,400 | )
Accrued interest payable |  |  | (213 | ) |  |  | - |  |  |  | (213 | ) |  |  | - |  |  |  | (213 | )
Derivative financial instruments |  |  | (227 | ) |  |  | - |  |  |  | (227 | ) |  |  | - |  |  |  | (227 | )
|  | As of December 31, 2019 |
|  | Carrying |  |  |  |  |  |  |  |  |  |  |  |  |
|  | amount |  |  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
Financial assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 13,694 |  |  | $ | 13,694 |  |  | $ | - |  |  | $ | - |  |  | $ | 13,694 |
Investment securities available-for-sale |  |  | 362,998 |  |  |  | 2,316 |  |  |  | 360,682 |  |  |  | - |  |  |  | 362,998 |
Bank stocks, at cost |  |  | 3,109 |  |  |  | n/a |  |  |  | n/a |  |  |  | n/a |  |  |  | n/a |
Loans, net |  |  | 532,180 |  |  |  | - |  |  |  | - |  |  |  | 538,427 |  |  |  | 538,427 |
Loans held for sale |  |  | 8,497 |  |  |  | - |  |  |  | 8,497 |  |  |  | - |  |  |  | 8,497 |
Accrued interest receivable |  |  | 4,557 |  |  |  | 2 |  |  |  | 1,895 |  |  |  | 2,660 |  |  |  | 4,557 |
Derivative financial instruments |  |  | 532 |  |  |  | - |  |  |  | 532 |  |  |  | - |  |  |  | 532 |
Financial liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Non-maturity deposits |  | $ | (687,985 | ) |  | $ | (687,985 | ) |  | $ | - |  |  | $ | - |  |  | $ | (687,985 | )
Time deposits |  |  | (147,063 | ) |  |  | - |  |  |  | (146,390 | ) |  |  | - |  |  |  | (146,390 | )
FHLB borrowings |  |  | (3,000 | ) |  |  | - |  |  |  | (3,000 | ) |  |  | - |  |  |  | (3,000 | )
Subordinated debentures |  |  | (21,651 | ) |  |  | - |  |  |  | (19,527 | ) |  |  | - |  |  |  | (19,527 | )
Other borrowings |  |  | (17,548 | ) |  |  | - |  |  |  | (17,548 | ) |  |  | - |  |  |  | (17,548 | )
Accrued interest payable |  |  | (404 | ) |  |  | - |  |  |  | (404 | ) |  |  | - |  |  |  | (404 | )
Derivative financial instruments |  |  | (50 | ) |  |  | - |  |  |  | (50 | ) |  |  | - |  |  |  | (50 | )
Transfers The Company did not transfer any assets or liabilities among levels during the nine months ended September 30, 2020 or during the year ended December 31, 2019. Valuation Methods for Instruments Measured at Fair Value on a Recurring Basis The following tables represent the Company’s financial instruments that are measured at fair value on a recurring basis at September 30, 2020 and December 31, 2019 allocated to the appropriate fair value hierarchy: Schedule of Fair Value, Assets Measured On Recurring Basis
(Dollars in thousands) |  |  |  |  |  |  |  |  |  |  |  |
|  |  |  |  | As of September 30, 2020 |
|  |  |  |  | Fair value hierarchy |
|  | Total |  |  | Level 1 |  |  | Level 2 |  |  | Level 3 |
Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Available-for-sale investment securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
U. S. treasury securities |  | $ | 2,047 |  |  | $ | 2,047 |  |  | $ | - |  |  | $ | - |
U. S. federal agency obligations |  |  | 18,988 |  |  |  | - |  |  |  | 18,988 |  |  |  | - |
Municipal obligations, tax exempt |  |  | 141,877 |  |  |  | - |  |  |  | 141,877 |  |  |  | - |
Municipal obligations, taxable |  |  | 48,379 |  |  |  | - |  |  |  | 48,379 |  |  |  | - |
Agency mortgage-backed securities |  |  | 83,565 |  |  |  | - |  |  |  | 83,565 |  |  |  | - |
Certificates of deposit |  |  | 4,674 |  |  |  | - |  |  |  | 4,674 |  |  |  | - |
Loans held for sale |  |  | 18,253 |  |  |  | - |  |  |  | 18,253 |  |  |  | - |
Derivative financial instruments |  |  | 2,366 |  |  |  | - |  |  |  | 2,366 |  |  |  | - |
Liabililties: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Derivative financial instruments |  |  | (227 | ) |  |  | - |  |  |  | (227 | ) |  |  | - |
|  |  |  |  | As of December 31, 2019 |
|  |  |  |  | Fair value hierarchy |
|  | Total |  |  | Level 1 |  |  | Level 2 |  |  | Level 3 |
Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Available-for-sale investment securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
U. S. treasury securities |  | $ | 2,316 |  |  | $ | 2,316 |  |  | $ | - |  |  | $ | - |
U. S. federal agency obligations |  |  | 4,106 |  |  |  | - |  |  |  | 4,106 |  |  |  | - |
Municipal obligations, tax exempt |  |  | 145,862 |  |  |  | - |  |  |  | 145,862 |  |  |  | - |
Municipal obligations, taxable |  |  | 46,779 |  |  |  | - |  |  |  | 46,779 |  |  |  | - |
Agency mortgage-backed securities |  |  | 162,031 |  |  |  | - |  |  |  | 162,031 |  |  |  | - |
Certificates of deposit |  |  | 1,904 |  |  |  | - |  |  |  | 1,904 |  |  |  | - |
Loans held for sale |  |  | 8,497 |  |  |  | - |  |  |  | 8,497 |  |  |  | - |
Derivative financial instruments |  |  | 532 |  |  |  | - |  |  |  | 532 |  |  |  | - |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Derivative financial instruments |  |  | (50 | ) |  |  | - |  |  |  | (50 | ) |  |  | - |
The Company’s investment securities classified as available-for-sale include U.S. treasury securities, U.S. federal agency obligations, municipal obligations, agency mortgage-backed securities and certificates of deposits. Quoted exchange prices are available for the Company’s U.S treasury securities, which are classified as Level 1. U.S. federal agency securities and agency mortgage-backed securities are priced utilizing industry-standard models that consider various assumptions, including time value, yield curves, volatility factors, prepayment speeds, default rates, loss severity, current market and contractual prices for the underlying financial instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace, can be derived from observable data, or are supported by observable levels at which transactions are executed in the marketplace. These measurements are classified as Level 2. Municipal obligations are valued using a type of matrix, or grid, pricing in which securities are benchmarked against U.S. treasury rates based on credit rating. These model and matrix measurements are classified as Level 2 in the fair value hierarchy. Changes in the fair value of available-for-sale securities are included in other comprehensive income to the extent the changes are not considered other-than-temporary impairments. Other-than-temporary impairment tests are performed on a quarterly basis and any decline in the fair value of an individual security below its cost that is deemed to be other-than-temporary results in a write-down of that security’s cost basis. Mortgage loans originated and intended for sale in the secondary market are carried at fair value. The mortgage loan valuations are based on quoted secondary market prices for similar loans and are classified as Level 2. Changes in the fair value of mortgage loans originated and intended for sale in the secondary market and derivative financial instruments are included in gains on sales of loans. The aggregate fair value, contractual balance (including accrued interest), and gain on loans held for sale were as follows: Schedule of Fair Value Contractual Balance and Gain Loss On Loans Held for Sale
|  | As of |  |  | As of |
|  | September 30, |  |  | December 31, |
(Dollars in thousands) |  | 2020 |  |  | 2019 |
Aggregate fair value |  | $ | 18,253 |  |  | $ | 8,497 |
Contractual balance |  |  | 17,864 |  |  |  | 8,316 |
Gain |  | $ | 389 |  |  | $ | 181 |
The Company’s derivative financial instruments consist of interest rate lock commitments and corresponding forward sales contracts on mortgage loans held for sale. The fair values of these derivatives are based on quoted prices for similar loans in the secondary market. The market prices are adjusted by a factor, based on the Company’s historical data and its judgment about future economic trends, which considers the likelihood that a commitment will ultimately result in a closed loan. These instruments are classified as Level 2. The amounts are included in other assets or other liabilities on the consolidated balance sheets and gains on sales of loans, net in the consolidated statements of earnings. The total amount of gains from changes in fair value of loans held for sale included in earnings were as follows: Schedule of Gains and Losses from Changes in Fair Value of Loans Held for Sale
|  | 2020 |  |  | 2019 |  |  | 2020 |  |  | 2019 |
|  | Three months ended |  |  | Nine months ended |
|  | September 30, |  |  | September 30, |
(Dollars in thousands) |  | 2020 |  |  | 2019 |  |  | 2020 |  |  | 2019 |
Interest income |  | $ | 148 |  |  | $ | 139 |  |  | $ | 344 |  |  | $ | 309 |
Change in fair value |  |  | 105 |  |  |  | (115 | ) |  |  | 208 |  |  |  | 87 |
Total change in fair value |  | $ | 253 |  |  | $ | 24 |  |  | $ | 552 |  |  | $ | 396 |
Valuation Methods for Instruments Measured at Fair Value on a Non-recurring Basis The Company does not record its loan portfolio at fair value. Collateral-dependent impaired loans are generally carried at the lower of cost or fair value of the collateral, less estimated selling costs. Collateral values are determined based on appraisals performed by qualified licensed appraisers hired by the Company and then further adjusted if warranted based on relevant facts and circumstances. The appraisals may utilize a single valuation approach or a combination of approaches including the comparable sales and income approach. Adjustments are routinely made in the appraisal process by the appraisers to adjust for differences between the comparable sales and income data available. Such adjustments are typically significant and result in a Level 3 classification of the inputs for determining fair value. Impaired loans are reviewed and evaluated at least quarterly for additional impairment and adjusted accordingly, based on the same factors identified above. The carrying value of the Company’s impaired loans was $10.6 million and $8.7 million, with an allocated allowance of $238,000 and $733,000, at September 30, 2020 and December 31, 2019, respectively. Real estate owned includes assets acquired through, or in lieu of, foreclosure and land previously acquired for expansion. Real estate owned is initially recorded at the fair value of the collateral less estimated selling costs. Subsequent valuations are updated periodically and are based upon independent appraisals, third party price opinions or internal pricing models. The appraisals may utilize a single valuation approach or a combination of approaches including the comparable sales and income approach. Adjustments are routinely made in the appraisal process by the appraisers to adjust for differences between the comparable sales and income data available. Such adjustments are typically significant and result in a Level 3 classification of the inputs for determining fair value. Real estate owned is reviewed and evaluated at least annually for additional impairment and adjusted accordingly, based on the same factors identified above. The following table presents quantitative information about Level 3 fair value measurements for impaired loans measured at fair value on a non-recurring basis as of September 30, 2020 and December 31, 2019. Schedule of Fair Value Measurements On Nonrecurring, Valuation Techniques
(Dollars in thousands) |  |  |  |  |  |  |  |  |  |
|  | Fair value |  |  | Valuation technique |  | Unobservable inputs |  | Range |
As of September 30, 2020 |  |  |  |  |  |  |  |  |  |  |  |
Impaired loans: |  |  |  |  |  |  |  |  |  |  |  |
One-to-four family residential real estate |  | $ | 87 |  |  | Sales comparison |  | Adjustment to appraised value |  |  | 0% |
Commercial |  |  | 78 |  |  | Sales comparison |  | Adjustment to comparable sales |  |  | 0%-68% |
Real estate owned |  |  | 1,488 |  |  | Sales comparison |  | Adjustment to appraised value |  |  | 10% |
As of December 31, 2019 |  |  |  |  |  |  |  |  |  |  |  |
Impaired loans: |  |  |  |  |  |  |  |  |  |  |  |
One-to-four family residential real estate |  | $ | 240 |  |  | Sales comparison |  | Adjustment to appraised value |  |  | 0%-25% |
Commercial real estate |  |  | 100 |  |  | Sales comparison |  | Adjustment to appraised value |  |  | 0%-15% |
Commercial |  |  | 678 |  |  | Sales comparison |  | Adjustment to comparable sales |  |  | 0%-75% |
Agriculture |  |  | 405 |  |  | Sales comparison |  | Adjustment to appraised value |  |  | 0%-30% |

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration